tiprankstipranks
Trending News
More News >

Solvonis Therapeutics Appoints Renowned Neuroscientist as Chief Scientific Officer

Story Highlights
  • Solvonis Therapeutics appoints Professor David Nutt as Chief Scientific Officer.
  • Nutt’s leadership expected to enhance Solvonis’ pipeline for addiction and mental health disorders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Solvonis Therapeutics Appoints Renowned Neuroscientist as Chief Scientific Officer

Confident Investing Starts Here:

Graft Polymer (UK) PLC ( (GB:SVNS) ) has issued an announcement.

Solvonis Therapeutics plc has appointed Professor David Nutt as Chief Scientific Officer, a move expected to enhance the company’s scientific strategy and clinical development. Professor Nutt, a leading authority in brain science and psychiatric medicine, will oversee the development of Solvonis’ expanding pipeline, including key programs targeting Alcohol Use Disorder and PTSD. His leadership is anticipated to reinforce Solvonis’ commitment to innovation in addressing urgent clinical needs, potentially impacting the company’s operations and industry positioning.

More about Graft Polymer (UK) PLC

Solvonis Therapeutics plc is a clinical-stage biopharmaceutical company focused on developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the London Stock Exchange, Solvonis is advancing a pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet needs, such as Alcohol Use Disorder and Post-Traumatic Stress Disorder.

Average Trading Volume: 14,599,829

Technical Sentiment Signal: Sell

Current Market Cap: £7.83M

Learn more about SVNS stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App